Two Sigma Advisers’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.24M | Buy |
284,600
+89,200
| +46% | +$1.02M | 0.01% | 907 |
|
|
2025
Q1 | $2.32M | Buy |
195,400
+116,300
| +147% | +$1.38M | 0.01% | 1099 |
|
|
2024
Q4 | $1.49M | Buy |
79,100
+20,000
| +34% | +$377K | ﹤0.01% | 1265 |
|
|
2024
Q3 | $1.33M | Sell |
59,100
-30,400
| -34% | -$683K | ﹤0.01% | 1275 |
|
|
2024
Q2 | $1.87M | Sell |
89,500
-88,400
| -50% | -$1.84M | ﹤0.01% | 1230 |
|
|
2024
Q1 | $2.62M | Buy |
177,900
+148,800
| +511% | +$2.19M | 0.01% | 1083 |
|
|
2023
Q4 | $300K | Buy |
29,100
+9,900
| +52% | +$102K | ﹤0.01% | 2098 |
|
|
2023
Q3 | $151K | Buy |
19,200
+4,000
| +26% | +$31.4K | ﹤0.01% | 2146 |
|
|
2023
Q2 | $152K | Buy |
15,200
+3,300
| +28% | +$33K | ﹤0.01% | 2141 |
|
|
2023
Q1 | $106K | Buy |
+11,900
| New | +$106K | ﹤0.01% | 2375 |
|
|
2022
Q2 | – | Sell |
-12,200
| Closed | -$171K | – | 2813 |
|
|
2022
Q1 | $171K | Buy |
+12,200
| New | +$171K | ﹤0.01% | 2416 |
|